| |
| |
|
| Insider
Information: |
Stonepine Capital, L.p. |
| Relationship: |
10% Owner |
| City: |
Bend |
| State: |
OR |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
23,887,407 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$18,554,963 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
23,887,407 |
|
|
| Total
Value |
$18,554,963 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vive Medical Inc |
VIVE |
10% Owner |
2015-11-24 |
18,397,682 |
|
0 |
Premium* |
|
|
Novelion Therapeutics Inc |
NVLN |
10% Owner |
2019-12-12 |
3,909,207 |
2016-09-13 |
0 |
Premium* |
|
|
Apollo Endosurgery, Inc |
APEN |
10% Owner |
2019-08-12 |
1,580,518 |
|
0 |
Premium* |
|
|
Chiasma, Inc |
CHMA |
10% Owner |
2021-08-05 |
0 |
2021-08-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CHMA |
Chiasma, Inc |
10% Owner |
– – • |
2021-08-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(6,770,000) |
0 |
0 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2019-12-12 |
4 |
B |
$0.70 |
$700 |
D/D |
1,000 |
3,909,207 |
2.37 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2019-12-11 |
4 |
B |
$0.69 |
$28 |
D/D |
40 |
3,908,207 |
2.37 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2019-12-10 |
4 |
B |
$0.69 |
$3,598 |
D/D |
5,202 |
3,908,167 |
2.37 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2019-12-09 |
4 |
B |
$0.70 |
$3,150 |
D/D |
4,500 |
3,902,965 |
2.37 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2019-12-06 |
4 |
B |
$0.70 |
$28 |
D/D |
40 |
3,898,465 |
2.37 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2019-12-05 |
4 |
B |
$0.70 |
$3,612 |
D/D |
5,160 |
3,898,425 |
2.37 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2019-11-22 |
4 |
B |
$0.75 |
$67,033 |
D/D |
89,845 |
3,893,265 |
2.45 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2019-10-11 |
4 |
B |
$0.65 |
$64,900 |
D/D |
100,000 |
3,803,420 |
2.45 |
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2019-09-23 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
3,703,420 |
|
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2019-08-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,000,000) |
1,580,518 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2018-12-27 |
4 |
S |
$3.00 |
$750,000 |
D/D |
(250,000) |
2,185,426 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2018-12-26 |
4 |
S |
$3.00 |
$1,500,000 |
D/D |
(500,000) |
2,435,426 |
0 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2018-11-21 |
4 |
B |
$3.61 |
$11,644 |
D/D |
3,230 |
2,935,426 |
2.37 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2018-11-19 |
4 |
B |
$3.40 |
$184,280 |
D/D |
54,200 |
2,932,196 |
2.45 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2018-11-02 |
4 |
B |
$5.00 |
$1,500,000 |
D/D |
300,000 |
2,877,996 |
2.45 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2018-01-03 |
4 |
B |
$5.78 |
$36,656 |
D/D |
6,339 |
2,577,996 |
2.37 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2018-01-02 |
4 |
B |
$5.73 |
$64,960 |
D/D |
11,343 |
2,571,657 |
2.45 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2017-12-29 |
4 |
B |
$5.56 |
$28,717 |
D/D |
5,163 |
2,560,314 |
2.37 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2017-12-26 |
4 |
B |
$5.00 |
$26,435 |
D/D |
5,287 |
2,555,151 |
2.37 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2017-12-22 |
4 |
B |
$5.00 |
$206,863 |
D/D |
41,399 |
2,549,864 |
2.45 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2017-12-21 |
4 |
B |
$4.94 |
$485,947 |
D/D |
98,324 |
2,508,465 |
2.45 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2017-12-20 |
4 |
B |
$4.50 |
$204,312 |
D/D |
45,434 |
2,410,141 |
2.45 |
- |
|
| APEN |
Apollo Endosurgery, Inc |
10% Owner |
– – • |
2017-08-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,364,707 |
|
- |
|
| NVLN |
Novelion Therapeutics Inc |
10% Owner |
– – • |
2016-09-15 |
4 |
B |
$1.55 |
$23,138 |
D/D |
14,928 |
5,778,496 |
2.37 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
